xanthine oxidase

This term refers to a specific enzyme critical to the purine degradation pathway. In a clinical context, it is most frequently discussed in relation to the treatment of hyperuricemia and gout, where pharmacological agents like allopurinol act as inhibitors to prevent the overproduction of uric acid.

As a specialized biochemical term, it is used almost exclusively in medical, pharmacological, and biological registers. It does not have a casual or metaphorical application in general English.